Paradoxically, we measured a significant decrease in aSMase activity in AD compared with CN and MCI, whereas nSMase activity was only slightly decreased, suggesting that the SMase pathway is not directly responsible for the increase in Cer and subsequent decrease in SM/Cer found in SF from our AD participants. This evidence concerns the gene CBLN1 and Alzheimer disease.